Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2005
03/30/2005CN1602310A Benzothiazoles compound
03/30/2005CN1602304A Deuterated substituted dihydrofuranones and medicaments containing these compounds
03/30/2005CN1602302A Biscyanophenylmethyl-triazole for use in prevention of breast cancer
03/30/2005CN1602299A Crystals of bicalutamide and process for their production
03/30/2005CN1602292A Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
03/30/2005CN1602207A Methods for inhibiting ocular processes
03/30/2005CN1602206A Pharmaceutical compositions based on azetidine derivatives
03/30/2005CN1602204A Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
03/30/2005CN1602200A Plant extract active as an immunostimulating agent
03/30/2005CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators
03/30/2005CN1602195A Quinazoline derivatives for the treatment of abnormal cell growth
03/30/2005CN1602192A Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1602190A Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis
03/30/2005CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution
03/30/2005CN1602172A Method and apparatus for the stimulation of hair growth
03/30/2005CN1602158A Food or pet food composition containing plant extract for bone health
03/30/2005CN1600783A Imidazopyridine derivatives
03/30/2005CN1600326A Medication for treating atrophy of cerebellum
03/30/2005CN1194990C Polypeptide motif bound with human CD95 and its polypeptide
03/30/2005CN1194987C Purified polypeptide with bioactiveity and medicine preparied from it for promoting growth and and development of animal's nerve cells and suppressing their apotosis
03/30/2005CN1194978C Phosphinous and phosphonic acid derivs. used as medicaments
03/30/2005CN1194976C Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
03/30/2005CN1194762C Gene therapy for cerebrovasclar disorders
03/30/2005CN1194746C Traditional Chinese medicine compound preparation for preventing and treating forest frog disease
03/30/2005CN1194745C Medicinal composition for high examination syndromes
03/30/2005CN1194742C Chinese medicinal composition with delaying senility and improving sleep functions, and preparing method thereof
03/30/2005CN1194713C Medicine for resisting senility, shrinking vagina, beautifying breast and stregthening male genitals and its production method
03/29/2005US6872852 Polyamine analogues as cytotoxic agents
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872838 Derivatives of water insoluble drugs which exhibit good activity and water solubility
03/29/2005US6872805 Hepatitis C virus inhibitors
03/29/2005US6872750 Modulating angiogenesis
03/29/2005US6872746 Isomeric fused pyrrolocarbazoles and isoindolones
03/29/2005US6872745 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
03/29/2005US6872744 Analgesics
03/29/2005US6872743 Antiinflammatory agents; sepsis shock; antiarthritic agents
03/29/2005US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
03/29/2005US6872737 Drugs such as 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5 -dione inhibitors of glycogen synthase kinase-3 (GSK-3), for prophylaxis of neurodegenerative disorders, cancer, hyperplasia, psoriasis, arteriosclerosis or restinosis
03/29/2005US6872732 Heterocyclic derivatives and medicinal use thereof
03/29/2005US6872731 Imidazo-pyridine derivatives as ligands for GABA receptors
03/29/2005US6872725 Crystallized p38 kinase inhibitors for treatment of rheumatoid arthritis
03/29/2005US6872722 Therapies for tissue damage resulting from ischemia
03/29/2005US6872721 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione
03/29/2005US6872720 Pyrazolo-triazine derivatives as ligands for gaba receptors
03/29/2005US6872712 Cyclic glycerophosphates and analogs thereof
03/29/2005US6872711 β-substituted β-aminoethyl phosphonate derivatives
03/29/2005US6872706 Hypoglycemic agents; antidiabetic agents; dietetics
03/29/2005US6872702 Cyclic peptide; antitumor agents; antiinflammatory agents; tissue remodeling
03/29/2005US6872390 Local anesthetic methods and kits
03/29/2005CA2425745C Expression of exogenous polynucleotide sequences in a vertebrate
03/29/2005CA2372409C Delivery of macromolecules into cells
03/29/2005CA2301732C Therapeutic combinations
03/29/2005CA2280447C Pyrrolo¬1,2-a|pyrazine derivatives as 5ht1a ligands
03/29/2005CA2268870C Heterocyclic carboxamides
03/29/2005CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/29/2005CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
03/29/2005CA2180950C Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
03/29/2005CA2176042C Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors
03/29/2005CA2097444C Angiotensin ii antagonist imidazole derivatives, their preparation and their therapeutic use
03/29/2005CA2049287C Expression of exogenous polynucleotide sequences in a vertebrate
03/24/2005WO2005026355A1 Method of evaluating cancerization degree
03/24/2005WO2005026354A1 Method of evaluating cancerization degree
03/24/2005WO2005026353A1 Method of evaluating cancerization degree
03/24/2005WO2005026352A1 Method of evaluating cancerization degree
03/24/2005WO2005026351A1 Method of evaluating cancerization degree
03/24/2005WO2005026350A1 Method of evaluating cancerization degree
03/24/2005WO2005026344A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis
03/24/2005WO2005026138A1 2-naphthylimino-1,3-thiazine derivative
03/24/2005WO2005026137A2 Modulators of atp-binding cassette transporters
03/24/2005WO2005026127A1 Plasminogen activator inhibitor-1 inhibitor
03/24/2005WO2005025601A1 Follistatin isoforms and uses thereof
03/24/2005WO2005025600A1 Drug inhibiting mobilization of adhesive cells into peripheral blood
03/24/2005WO2004078145A3 Combination therapy with glatiramer acetate and simvastatin for the treatment of multiple sclerosis
03/24/2005WO2004067554A3 Compositions and methods of tolerizing a primate to an antigen
03/24/2005WO2004050072A8 Water-soluble composition containing coenzyme q10
03/24/2005WO2004000197A3 Quick dissolve compositions and tablets based thereon
03/24/2005WO2003103478A3 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
03/24/2005WO2003090687A9 Using heat shock proteins to increase immune response
03/24/2005WO2003079970A8 4-(diarylmethyl)-1-piperazinyl derivatives
03/24/2005WO2003059291A3 Treatment of bone disorders with skeletal anabolic drugs
03/24/2005WO2002092759A9 Molecules for disease detection and treatment
03/24/2005WO2002058450A3 Regulation of cell growth by muc1
03/24/2005US20050065346 anticoagulants; thrombosis; factor x inhibitor
03/24/2005US20050065340 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia
03/24/2005US20050065328 Gastrokines and derived peptides including inhibitors
03/24/2005US20050065325 Monoclonal antibody for use as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders
03/24/2005US20050065212 Use of at least one 10-hydroxy-2-decenoic acid derivative in compositions for treating the cuteous signs of aging
03/24/2005US20050065211 Ester derivatives
03/24/2005US20050065205 Administering protein kinase C activator such as macrocyclic lactone; mixture with enzyme inhibitor and carrier
03/24/2005US20050065196 Azole compound and medicinal use thereof
03/24/2005US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
03/24/2005US20050065191 Central nervous system disorders; therapy for diseases of glutamate receptor signal transmission
03/24/2005US20050065186 Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
03/24/2005US20050065185 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
03/24/2005US20050065170 Compounds
03/24/2005US20050065165 Method of treating certain cancers using an estrogen agonist/antagonist
03/24/2005US20050065163 Platelet adenosine diphosphate receptor antagonists
03/24/2005US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
03/24/2005US20050065157 Carbazole derivatives and their use as npy5 receptor antagonists
1 ... 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 ... 1564